(Q37227687)

English

Prediction of survival by [18F]fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: results of the ACRIN 6668/RTOG 0235 trial

scientific article published on 16 September 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Prediction of survival by [18F]fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: results of the ACRIN 6668/RTOG 0235 trial (English)

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

chemoradiotherapy

0 references

0 references

positron emission tomography

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Mitchell Machtay

1

object named as

Mitchell Machtay

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

16

object named as

Ritsuko Komaki

1 reference

Europe PubMed Central

19 August 2017

PMC publication ID

19

object named as

Abass Alavi

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

author name string

Fenghai Duan

2

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Barry A Siegel

3

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Bradley S Snyder

4

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Jeremy J Gorelick

5

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Janet S Reddin

6

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Reginald Munden

7

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Douglas W Johnson

8

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Larry H Wilf

9

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Albert DeNittis

10

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Nancy Sherwin

11

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Kwan Ho Cho

12

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Seok-Ki Kim

13

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Gregory Videtic

14

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Donald R Neumann

15

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Homer Macapinlac

17

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Jeffrey D Bradley

18

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

language of work or name

0 references

publication date

16 September 2013

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

31

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

30

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

3823-3830

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Response assessment using 18F-FDG PET early in the course of radiotherapy correlates with survival in advanced-stage non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795891

6 September 2017

Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795891

6 September 2017

PET scans in radiotherapy planning of lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795891

6 September 2017

Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variables

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795891

6 September 2017

Non-small-cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795891

6 September 2017

Positron emission tomography/computed tomography in lung cancer staging, prognosis, and assessment of therapeutic response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795891

6 September 2017

A phase II comparative study of gross tumor volume definition with or without PET/CT fusion in dosimetric planning for non-small-cell lung cancer (NSCLC): primary analysis of Radiation Therapy Oncology Group (RTOG) 0515.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795891

6 September 2017

Primary tumor standardized uptake value measured on fluorodeoxyglucose positron emission tomography is of prognostic value for survival in non-small cell lung cancer: update of a systematic review and meta-analysis by the European Lung Cancer Workin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795891

6 September 2017

Qualification of PET scanners for use in multicenter cancer clinical trials: the American College of Radiology Imaging Network experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795891

6 September 2017

Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795891

6 September 2017

High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795891

6 September 2017

Large decreases in standardized uptake values after definitive radiation are associated with better survival of patients with locally advanced non-small cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795891

3 September 2018

Impact of the definition of peak standardized uptake value on quantification of treatment response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795891

3 September 2018

Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patien

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795891

3 September 2018

Prediction of residual metabolic activity after treatment in NSCLC patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795891

3 September 2018

Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795891

3 September 2018

Prognostic implication of dual-phase PET in adenocarcinoma of the lung

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795891

3 September 2018

Imaging cellular proliferation during chemo-radiotherapy: a pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795891

3 September 2018

Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795891

3 September 2018

Metabolic tumor burden predicts for disease progression and death in lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795891

3 September 2018

A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795891

3 September 2018

Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795891

3 September 2018

Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795891

3 September 2018

Association Between Pulmonary Uptake of Fluorodeoxyglucose Detected by Positron Emission Tomography Scanning After Radiation Therapy for Non–Small-Cell Lung Cancer and Radiation Pneumonitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795891

4 December 2018

Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

¹⁸F-FDG PET-CT during chemo-radiotherapy in patients with non-small cell lung cancer: the early metabolic response correlates with the delivered radiation dose

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2012.47.5947

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37227687&oldid=2132175638"